Keyphrases
Aberrant Transcription
31%
Acute Myeloid Leukemia
100%
Addiction
31%
Adoptive Cell Therapy
31%
Adoptive Cell Transfer
84%
Adoptive Immunotherapy
34%
Anti-leukemia
31%
Anti-melanoma
31%
ASF1
38%
Breast Cancer
31%
CD8+ T Cells
37%
Cell-based
31%
Chemical Genomics
31%
Chromatin Remodeling
54%
Ciclopirox
31%
Co-transfer
31%
Cytotoxic T-lymphocyte antigen-4 (CTLA-4)
31%
Diffuse Large B-cell Lymphoma (DLBCL)
31%
DNA Damage
31%
Double-strand Breaks
31%
Effector Memory T Cells
39%
Eukaryotic Translation Initiation Factor 4E (eIF4E)
38%
Fluorescent Probe
31%
Genetic Screening
31%
Heat Shock Protein 90 (Hsp90)
62%
Inhibitory Activity
31%
IREM-1
31%
Leukemia
38%
Mammalian Target of Rapamycin (mTOR)
31%
Melanoma
44%
Melanoma Treatment
39%
Memory CD8+ T Cells
44%
Memory T Cells
31%
Monoclonal Antibody
31%
Mouse Model
31%
MTOR Pathway
31%
Myosin Heavy Chain (MyHC)
31%
Overexpression
38%
Parthenolide
62%
PI3 Kinase Signaling
31%
Primary Diffuse Large B-cell Lymphoma
31%
PU-H71
31%
Purine Scaffold
31%
Radioresistance
37%
Signalosome
31%
Synergism
31%
Targeted Therapy
36%
TLK1
48%
Transcription Factor
31%
Tumor-specific
62%
Immunology and Microbiology
Adoptive Immunotherapy
34%
Arabidopsis thaliana
16%
C57BL 6 Mouse
13%
Cell Activity
8%
Cell Line
25%
Cell Population
19%
Chromatin Assembly and Disassembly
62%
Chromatin Structure
10%
Complement Dependent Cytotoxicity
6%
CTLA-4
31%
Cytotoxic T-Cell
62%
DNA Repair
6%
Episome
10%
Extract
18%
Flower Development
16%
Heat Shock
31%
Immune Response
8%
Immunotherapy
71%
Initiation Factor 4E
41%
Intravenous Immunoglobulin
6%
Leukemia Cell
6%
Lymphocytic Choriomeningitis Virus
13%
Melanoma Cell
6%
Memory T Cell
31%
Monoclonal Antibody
31%
Mouse
94%
Mouse Model
41%
Myeloid
31%
Nuclear Division
16%
Nucleosome
6%
Phosphorylation and Dephosphorylation
10%
Plasmid
26%
Radioresistance
37%
Splenocyte
7%
Steady State
10%
Syngenic
7%
T Cell
37%
Transfer Cell
71%
Tumor Antigen
7%
Untranslated Region
6%
Medicine and Dentistry
Acute Myeloid Leukemia
51%
B-Cell Lymphoma
10%
C57BL/6
10%
Cancer
5%
Cell Activity
8%
Cell Population
8%
Central Nervous System
31%
Combination Drug
5%
Core Binding Factor
31%
Corpus Callosum
5%
CTLA-4
31%
Cytoprotective Agent
10%
Cytotoxic T-Cell
31%
Diffuse Large B-Cell Lymphoma
31%
Dizziness
5%
Endometrial Cancer
10%
Fluorescence in Situ Hybridization
5%
Fusion Protein
5%
Headache
5%
Heavy Chain
31%
Immune Response
8%
Immunoglobulin Heavy Chain
10%
Immunohistochemistry
10%
Immunotherapy
62%
In Vitro
8%
Large-Cell Lymphoma
5%
Leukemia
31%
Leukemia Cell
15%
Lymphocytic Choriomeningitis Virus
10%
Magnetic Resonance Imaging
5%
Malignant Neoplasm
8%
Mammalian Target of Rapamycin
31%
Mammalian Target of Rapamycin Inhibitor
5%
Myosin
31%
Neoplasm
28%
Nodular Melanoma
62%
Non-Hodgkin Lymphoma
5%
Parthenolide
31%
Pharmacokinetics
5%
Phosphoinositide 3-Kinase
31%
Primary Central Nervous System Lymphoma
15%
Protein-Protein Interaction
5%
Specific Tumor
39%
Splenium
5%
T Cell
34%
Transcription Factor RUNX1
5%
Transcription Factors
31%
Transfer Cell
53%
Tumor Antigen
7%
Whole Brain Radiotherapy
5%
